QS-1189

N/A

Report date: 2023/05/05 17:36:56
NME

Base Information

Drug NameQS-1189
Drug Alias NameQS-1189
ClassificationOther
Mechanisms of ActionCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7
Therapy Area/IndicationsLymphoma, Mantle-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Ulsan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Ulsan
Inactive CompaniesN/A
Active IndicationsLymphoma, Mantle-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A